TR200003587T2 - Nosatiasin antibiyotikleri. - Google Patents

Nosatiasin antibiyotikleri.

Info

Publication number
TR200003587T2
TR200003587T2 TR2000/03587T TR200003587T TR200003587T2 TR 200003587 T2 TR200003587 T2 TR 200003587T2 TR 2000/03587 T TR2000/03587 T TR 2000/03587T TR 200003587 T TR200003587 T TR 200003587T TR 200003587 T2 TR200003587 T2 TR 200003587T2
Authority
TR
Turkey
Prior art keywords
nosatiacin
antibiotics
new
iii
antibiotic compounds
Prior art date
Application number
TR2000/03587T
Other languages
English (en)
Inventor
E. Leet John
R. Gustavson Donald
M. Brown Daniel
Turner Laura
Brown Kimberly
Li Wenying
S. Lam Kin
A. Ax Helen
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of TR200003587T2 publication Critical patent/TR200003587T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Nosatiasin I,II ve III de olmak üzere yeni tiazolil peptid antibiyotik bilesikleri içerilmektedir. Ayni zamanda, yeni mikroorganizma ATCC-202099 içerilmektedir.
TR2000/03587T 1998-07-16 1999-07-13 Nosatiasin antibiyotikleri. TR200003587T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9302198P 1998-07-16 1998-07-16
US10871698P 1998-11-17 1998-11-17

Publications (1)

Publication Number Publication Date
TR200003587T2 true TR200003587T2 (tr) 2001-06-21

Family

ID=26786568

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03587T TR200003587T2 (tr) 1998-07-16 1999-07-13 Nosatiasin antibiyotikleri.

Country Status (17)

Country Link
US (1) US6218398B1 (tr)
EP (1) EP1096939A4 (tr)
JP (1) JP2002520365A (tr)
KR (1) KR20010071913A (tr)
CN (2) CN1133437C (tr)
AU (1) AU745333B2 (tr)
BR (1) BR9912042A (tr)
CA (1) CA2337398A1 (tr)
CZ (1) CZ2001182A3 (tr)
HU (1) HUP0102903A2 (tr)
ID (1) ID27775A (tr)
IL (1) IL139650A0 (tr)
NO (1) NO20010250L (tr)
NZ (1) NZ509306A (tr)
PL (1) PL345657A1 (tr)
TR (1) TR200003587T2 (tr)
WO (1) WO2000003722A1 (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287827B1 (en) 1999-05-05 2001-09-11 Bristol-Myers Squibb Company Halo- or hydroxy-substituted nocathiacin antibiotics
US20020055465A1 (en) * 2000-08-14 2002-05-09 Wenying Li Nocathiacin antibiotics prepared by biotransformation or chemical methods
US20020065219A1 (en) * 2000-08-15 2002-05-30 Naidu B. Narasimhulu Water soluble thiazolyl peptide derivatives
DE60238481D1 (de) * 2001-04-25 2011-01-13 Wyeth Corp Im wesentlichen reine glycopeptid-antibiotika ac-98-1; ac-98-2; ac-98-3; ac-98-4 und ac-98-5
US6713448B2 (en) 2001-04-25 2004-03-30 Wyeth Holdings Corporation Substantially pure glycopeptide antibiotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 and AC-98-5
US7022667B2 (en) * 2002-07-03 2006-04-04 Bristol-Myers Squibb Company O-derivatized nocathiacin derivatives
US8402040B2 (en) 2004-08-20 2013-03-19 Morphotrust Usa, Inc. Method and system to authenticate an object
AU2005327139A1 (en) * 2004-09-22 2006-08-17 Merck & Co., Inc. Antibiotic compound
WO2007127135A2 (en) * 2006-04-24 2007-11-08 Merck & Co., Inc. Antibiotic compounds
CN101153274B (zh) * 2006-09-29 2010-12-01 中国科学院上海生命科学研究院 提高利福霉素产量的方法
US20080242597A1 (en) * 2006-10-20 2008-10-02 Kun Liu Antibiotic compounds
US20080132500A1 (en) * 2006-10-20 2008-06-05 Kun Liu Antibiotic compounds
CN102008436B (zh) * 2010-11-18 2012-07-18 中国药科大学 含乳化剂的诺卡沙星抗生素药物组合物
CN102028933A (zh) * 2010-11-18 2011-04-27 中国药科大学 含脂质材料的诺卡沙星抗生素的药物组合物
CN102018953B (zh) * 2010-11-18 2013-05-01 南京碧迪可医药科技有限公司 含诺卡沙星抗生素的药物组合物
CN102952760B (zh) * 2011-08-25 2014-04-02 天津工业生物技术研究所 一株能将奎宁酮转化为(s)-3-奎宁醇的红串红球菌及转化方法
CN102952761B (zh) * 2011-08-25 2014-01-15 天津工业生物技术研究所 一株能将奎宁酮转化为(r)-3-奎宁醇的诺卡氏菌及转化方法
CN107469068B (zh) * 2017-08-04 2021-06-22 南京碧迪可医药科技有限公司 一种硫肽环素的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634853A5 (de) 1978-06-08 1983-02-28 Sandoz Ag Schwefelhaltige metabolite, ihre herstellung und verwendung in arznei- und futtermitteln.
US5451581A (en) 1993-05-21 1995-09-19 Lee; May D. Antibiotic LL-14E605β and O-methyl-LL-14E605β

Also Published As

Publication number Publication date
IL139650A0 (en) 2002-02-10
CN1242052C (zh) 2006-02-15
JP2002520365A (ja) 2002-07-09
US6218398B1 (en) 2001-04-17
BR9912042A (pt) 2001-04-03
EP1096939A4 (en) 2001-08-22
CN1309566A (zh) 2001-08-22
EP1096939A1 (en) 2001-05-09
HUP0102903A2 (hu) 2002-05-29
NZ509306A (en) 2002-07-26
AU745333B2 (en) 2002-03-21
KR20010071913A (ko) 2001-07-31
WO2000003722A1 (en) 2000-01-27
NO20010250L (no) 2001-03-07
AU5098199A (en) 2000-02-07
PL345657A1 (en) 2002-01-02
CN1133437C (zh) 2004-01-07
NO20010250D0 (no) 2001-01-15
CN1515674A (zh) 2004-07-28
CA2337398A1 (en) 2000-01-27
CZ2001182A3 (cs) 2002-01-16
ID27775A (id) 2001-04-26

Similar Documents

Publication Publication Date Title
TR200003587T2 (tr) Nosatiasin antibiyotikleri.
TR199501527A2 (tr) Yeni peptid bilesimleri.
PT1265971E (pt) Utilizacao nova de uma composicao bioadesiva compreendendo uma proteina polifenolica
BR9808491A (pt) Compostos calcilìticos
DE69930818D1 (de) Neuartige antibiotika
UY34152A (es) ?oxazolidinonas substituidas y su uso?.
ATE221887T1 (de) Substituierte 1,2,4-triazolo(3,4,-a)phthalazin- derivate als gaba-alpha 5-liganden
TR200000006T2 (tr) Yeni formülasyon.
TR199501255A2 (tr) Immunomodülatör tesirli yeni peptidler.
MXPA01010403A (es) Agentes quimiotacticos e inhibidores derivados de osteopontina y usos de los mismos.
AU1685797A (en) Rapid microbial protease assay
AU4714297A (en) Metalloproteinase inhibitors
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
AU8973398A (en) Organic compounds
DE69625910D1 (de) Penamsulfone als beta-laktamase inhibitoren
DE60042753D1 (de) Von antibiotika
AU3616497A (en) Cyclic decapeptide antibiotics
AU4815497A (en) Biocontrol of fungal soilborne pathogens by (pythium oligandrum)
FR2676059B1 (fr) Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
RU95114858A (ru) Новый пептидный фрагмент, обладающий биологической активностью инсулина
RU98112850A (ru) Штамм бактерий bacillus licheniformis, обладающий антивирусной и антибактериальной активностью
TR200103662T2 (tr) Yeni kalpainler ve bunların kullanılması
ATE313624T1 (de) Bacillus proteasen
ITGE960040A0 (it) Pentapeptide.
FR2707090B1 (fr) Famille de Peptides, appelés Xénoxinés.